#Leukemia patient Becky Yu is a living testament to the importance of #clinicaltrials. Diagnosed with acute lymphocytic leukemia (ALL) in 2019, Yu enrolled in a clinical trial at Penn Medicine and is now enjoying life cancer-free. The trial, led by oncologist Selina Luger, MD, and colleagues on the ECOG-ARIN Cancer Research Group (ecog_arin), is designed to reduce the chances of #relapse. "Based on what we learned from this study, we've improved the outcomes for patients with #ALL," says Luger. "This progress is only possible through clinical trials." 🔗 in bio for Becky's full story. #clinicaltrial #cancerclinicaltrial #acutelymphocyticleukemia #cancertreatment